EE200100079A - Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus - Google Patents

Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus

Info

Publication number
EE200100079A
EE200100079A EEP200100079A EEP200100079A EE200100079A EE 200100079 A EE200100079 A EE 200100079A EE P200100079 A EEP200100079 A EE P200100079A EE P200100079 A EEP200100079 A EE P200100079A EE 200100079 A EE200100079 A EE 200100079A
Authority
EE
Estonia
Prior art keywords
medicament
preparation
treatment
cell proliferation
abnormal cell
Prior art date
Application number
EEP200100079A
Other languages
English (en)
Inventor
Bissery Marie-Christine
Vrignaud Patricia
Roberts Simon
Brealey Clive
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115401A external-priority patent/EP0982027A1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200100079A publication Critical patent/EE200100079A/et
Publication of EE04903B1 publication Critical patent/EE04903B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EEP200100079A 1998-08-17 1999-08-13 Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette n„htud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus EE04903B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115401A EP0982027A1 (en) 1998-08-17 1998-08-17 Taxoid derivatives for treating abnormal cell proliferation of the brain
US9958198P 1998-09-08 1998-09-08
PCT/EP1999/006291 WO2000009120A1 (en) 1998-08-17 1999-08-13 New use of taxoid derivatives

Publications (2)

Publication Number Publication Date
EE200100079A true EE200100079A (et) 2002-08-15
EE04903B1 EE04903B1 (et) 2007-10-15

Family

ID=26149540

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100079A EE04903B1 (et) 1998-08-17 1999-08-13 Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette n„htud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus

Country Status (19)

Country Link
US (1) US6346543B1 (et)
EP (1) EP1109547A1 (et)
JP (1) JP5354762B2 (et)
KR (1) KR100710533B1 (et)
AU (1) AU766168B2 (et)
BG (1) BG65365B1 (et)
CA (1) CA2340921C (et)
CZ (1) CZ293959B6 (et)
EE (1) EE04903B1 (et)
HU (1) HU230235B1 (et)
ID (1) ID27545A (et)
IL (1) IL141238A0 (et)
ME (1) ME00533B (et)
NO (1) NO327296B1 (et)
NZ (1) NZ509965A (et)
RS (1) RS52011B (et)
SK (1) SK285212B6 (et)
TR (1) TR200100557T2 (et)
WO (1) WO2000009120A1 (et)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP1020188A1 (en) * 1999-01-13 2000-07-19 Aventis Pharma S.A. New use of taxoid derivatives
EP1274720A4 (en) * 2000-04-12 2004-08-18 Human Genome Sciences Inc FUSION PROTEINS CONTAINING ALBUMIN
WO2002097038A2 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
PT1463751E (pt) 2001-12-21 2013-08-26 Human Genome Sciences Inc Proteínas de fusão de albumina
EP1463752A4 (en) * 2001-12-21 2005-07-13 Human Genome Sciences Inc ALBUM INFUSION PROTEINS
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
FR2926551A1 (fr) 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
US8637466B2 (en) 2008-08-11 2014-01-28 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
EP2493466B1 (en) 2009-10-29 2021-03-10 Sanofi Mature IP Novel antitumoral use of cabazitaxel
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
NZ628565A (en) * 2012-02-10 2016-03-31 Aventis Pharma Sa New pediatric uses of cabazitaxel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2696459B1 (fr) 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
TW467896B (en) 1993-03-19 2001-12-11 Bristol Myers Squibb Co Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
US5481018A (en) 1995-03-31 1996-01-02 The Dow Chemical Company Amino nitrile intermediate for the preparation of alanine diacetic acid
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides

Also Published As

Publication number Publication date
EP1109547A1 (en) 2001-06-27
ME00533B (me) 2011-10-10
YU7901A (sh) 2003-12-31
HUP0103748A3 (en) 2003-01-28
HU230235B1 (hu) 2015-10-28
EE04903B1 (et) 2007-10-15
AU766168B2 (en) 2003-10-09
HUP0103748A2 (hu) 2002-04-29
NO327296B1 (no) 2009-06-02
ID27545A (id) 2001-04-12
SK2302001A3 (en) 2001-09-11
SK285212B6 (sk) 2006-09-07
NO20010654L (no) 2001-02-07
WO2000009120A1 (en) 2000-02-24
CA2340921C (en) 2009-01-06
BG65365B1 (bg) 2008-04-30
BG105264A (en) 2001-11-30
AU5741999A (en) 2000-03-06
CA2340921A1 (en) 2000-02-24
JP2002522490A (ja) 2002-07-23
US6346543B1 (en) 2002-02-12
NO20010654D0 (no) 2001-02-07
KR100710533B1 (ko) 2007-04-23
KR20010085396A (ko) 2001-09-07
TR200100557T2 (tr) 2001-07-23
CZ2001604A3 (en) 2001-06-13
IL141238A0 (en) 2002-03-10
CZ293959B6 (cs) 2004-08-18
WO2000009120A8 (en) 2001-04-05
JP5354762B2 (ja) 2013-11-27
NZ509965A (en) 2003-09-26
RS52011B (sr) 2012-04-30

Similar Documents

Publication Publication Date Title
EE04903B1 (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette n„htud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus
IL146119A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUP0200556A3 (en) Medicament for treating diabetes
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
DE60018298D1 (de) Ophtalmologische medikamentenzuführvorrichtung
IL141057A0 (en) Laser for skin treatment
EE04175B1 (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
EE04851B1 (et) 4H-1-bensopüraan-4-ooni derivaatide kasutamine ravimi valmistamiseks silelihasrakkude proliferatsiooni inhibeerimiseks
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
ZA99526B (en) Moistened cosmetic eye treatment pads.
EE05109B1 (et) Sulfoonamiidi derivaadid, nende kasutamine meditsiinis ning meetod nende valmistamiseks
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO20001870D0 (no) Ny fremgangsmõte for behandling
IL141295A0 (en) Use of derivatives of aryl (or heteroaryl) azolycarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
IL137186A0 (en) Device for inhaling medicament
AU1585101A (en) Absorbent article with skin treatment means
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
EE05211B1 (et) Saredutandi ja selle farmatseutiliselt vastuv?etavate soolade kasutamine meeleoluh„irete, kohanemish„irete v?i segatpi „rev-depressiivsete h„irete raviks v?i v„ltimiseks kasulike ravimite valmistamiseks
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
EE200200605A (et) Asendatud akrüloüüldistamütsiini derivaadi kasutamine ravimi valmistamiseks, mis on ette nähtud glutatiooni kõrge tasemega seotud kasvajate raviks
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
AU1243101A (en) High dose folic acid for the treatment of hyperhomocysteinemia
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231